Biotech firm Maze Therapeutics raises $140 million in US IPO-March 2024-www.financetom.com

Biotech firm Maze Therapeutics raises $140 million in US IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Biotech firm Maze Therapeutics raises $140 million in US IPO

Jan 30, 2025 4:54 PM

Jan 30 (Reuters) - Maze Therapeutics said on Thursday

that it raised $140 million in an initial public offering,

setting the stage for a debut that could make the kidney disease

drug developer the first U.S. biotech listing this year.

Maze priced the offering at $16 per share, within its

indicated range of $15 to $17.

Previous page： Grocery retailer Sprouts' Q3 sales miss estimates Next page： OTG Acquisition Corp. I Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing on or about November 3, 2025

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Grocery retailer Sprouts' Q3 sales miss estimates

Oct 29, 2025

Overview * Sprouts Q3 net sales grow 13% yr/yr to $2.2 bln, missing analyst expectations * Diluted EPS for Q3 rises to $1.22 from $0.91 last year * Company announces new $1 bln share repurchase program Outlook * Company sees Q4 comparable store sales growth of 0.0% to 2.0% * Sprouts forecasts Q4 diluted EPS between $0.86 and $0.90 *...

OTG Acquisition Corp. I Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing on or about November 3, 2025

Oct 29, 2025

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OTG Acquisition Corp. I (the “Company”), a special purpose acquisition company, today announced that, commencing on or about November 3, 2025, holders of the units sold in the Company’s initial public offering completed on September 15, 2025 (the “offering”), may elect to separately trade the ordinary shares and warrants included in the...

Paramount Announces Third Quarter 2025 Results

Oct 29, 2025

– Leases over 1,236,000 square feet through September – NEW YORK--(BUSINESS WIRE)-- Paramount Group, Inc. ( PGRE ) (“Paramount” or the “Company”) filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 today and reported results for the third quarter. Proposed Merger On September 17, 2025, the Company entered into an agreement to be acquired...

Parex Resources Announces Its Proposal to Acquire GeoPark and an 11.8% Ownership Position

Oct 29, 2025

CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Parex Resources Inc. ( PARXF ) (“Parex” or the “Company”) announces that it submitted a Proposal (the “Proposal”) to the Board of Directors of GeoPark ( GPRK ) to acquire all outstanding common shares of GeoPark ( GPRK ) for US$9.00 per share in cash. Following a lack of constructive engagement with,...